Brand_Finance-最具价值和实力的制药、医疗器械和医疗保健服务品牌年度报告（英文）-2021.6-23页_14mb

Summary of Healthcare 2021 Annual Report

Core Content

The Healthcare 2021 report by Brand Finance provides an in-depth analysis of the most valuable and strongest brands in the pharmaceutical, medical devices, and healthcare services sectors. It highlights the impact of the COVID-19 pandemic on brand value and outlines the strategies that have helped certain brands thrive in the crisis.

Main Points

Brand Finance Overview

• Brand Finance is a leading brand valuation consultancy, established in 1996.
• The company bridges the gap between marketing and finance.
• It evaluates over 5,000 global brands annually and publishes nearly 100 reports yearly.
• Offers a unique blend of expertise across marketing, finance, and brand strategy.
• Recognized for its technical credibility, being a chartered accountancy firm and a pioneer in ISO standards for brand valuation and evaluation.

Key Insights from the Report

Pharma Sector

• Johnson & Johnson retained the top spot as the world's most valuable pharma brand with a brand value of US$10.8 billion, despite a 1% decline in value.

• The COVID-19 vaccine race significantly boosted brand values for several pharmaceutical companies:

  • Pfizer increased its brand value by 6% to US$4.0 billion.
  • AstraZeneca saw an 18% increase to US$3.2 billion.
  • Sinopharm experienced the most dramatic growth with an 58% increase to US$2.4 billion.

• Bristol Myers Squibb was the fastest-growing brand in the ranking, rising from 13th to 5th with an 84% increase in brand value to US$4.1 billion, driven by its acquisition of Celgene Corporation.

• Four new entrants joined the ranking:

  • Guangzhou Pharmaceuticals Corporation (US$1.5 billion, 19th)
  • CSL (US$827 million, 23rd)
  • Sandoz (US$643 million, 24th)
  • Yunnan Baiyao (US$621 million, 25th)

• Roche was identified as the strongest pharma brand with a Brand Strength Index (BSI) score of 74.2 and an AA rating.

Medical Devices Sector

• Medtronic remained the top brand with a value of US$9.3 billion, leading 15 other brands that account for 73.9% of the total brand value.
• BD was the strongest brand in the sector with a BSI score of 75.2 and an AA+ rating, attributed to its holistic CSR strategy and 4% increase in brand value to US$4.5 billion.
• Coloplast was the only brand in the ranking to increase its value by 20%, driven by organic growth and an acquisition of Nine Continents Medical.
• The sector as a whole saw a 3% decline in brand value, with most brands experiencing a drop.

Healthcare Services Sector

• UnitedHealthcare remained the most valuable healthcare services brand with a value of US$27.3 billion, despite a 4% decline.
• The sector was impacted by the pandemic, with some companies experiencing significant revenue drops.
• The report emphasizes the importance of brand strength and strategic acquisitions in maintaining and growing brand value.

Sector Reputation Analysis

• The report includes a Sector Reputation Analysis, highlighting the reputation of the healthcare sector as a whole.
• Brands are evaluated based on marketing investment, stakeholder equity, and business performance.
• Brand strength is a crucial driver of brand value, with the BSI and brand ratings used as key indicators.

Brand Spotlight

• Optum: A key brand in the healthcare services sector, noted for its strategic growth and impact on brand value.
• BD was highlighted for its holistic CSR strategy, which contributed to its strong brand value and reputation.

Methodology and Services

• Brand Finance uses transparent methodologies and ISO standards for brand valuation and evaluation.
• The report outlines various services offered by Brand Finance:
  • Consulting Services
  • Brand Evaluation Services
  • Communications Services
  • Educational Programs and certifications through the Brand Finance Institute (BFI).
• Brand Finance Network supports clients with brand strategy and communications across its global operations.

Conclusion

• Despite the pandemic's challenges, the healthcare sector has shown resilience, with certain brands experiencing significant growth.
• Brand strength and strategic acquisitions have played a critical role in maintaining brand value.
• Global brand value rankings provide insights into the market position and performance of leading healthcare brands, with the United States and China being the dominant markets in the pharmaceutical and medical devices sectors.

Brand Value by Country

• United States dominated both sectors, accounting for 46.9% of total pharma brand value and 73.9% of medical devices brand value.
• China was a strong performer, contributing 8.9% to pharma brand value and 11.3% to medical devices brand value.
• Switzerland and Germany were also significant contributors, with notable brand values in the pharma and medical devices sectors.

Key Figures

Final Thoughts

The report underscores the importance of brand value as a critical asset in the healthcare industry. It also highlights the role of strategic growth, CSR initiatives, and global market dynamics in shaping brand performance and value.